O
OrbiMed’s Bausch Health BHC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-2,399,880
| Closed | -$37.2M | – | 136 |
|
2020
Q1 | $37.2M | Sell |
2,399,880
-783,220
| -25% | -$12.1M | 0.63% | 46 |
|
2019
Q4 | $95.2M | Sell |
3,183,100
-129,200
| -4% | -$3.87M | 1.36% | 27 |
|
2019
Q3 | $72.4M | Sell |
3,312,300
-428,400
| -11% | -$9.36M | 1.37% | 24 |
|
2019
Q2 | $94.3M | Hold |
3,740,700
| – | – | 1.46% | 18 |
|
2019
Q1 | $92.4M | Buy |
3,740,700
+140,400
| +4% | +$3.47M | 1.43% | 19 |
|
2018
Q4 | $66.5M | Buy |
3,600,300
+1,696,400
| +89% | +$31.3M | 1.23% | 26 |
|
2018
Q3 | $48.9M | Buy |
+1,903,900
| New | +$48.9M | 0.59% | 52 |
|
2018
Q1 | – | Sell |
-76,800
| Closed | -$1.6M | – | 131 |
|
2017
Q4 | $1.6M | Sell |
76,800
-118,100
| -61% | -$2.45M | 0.02% | 122 |
|
2017
Q3 | $2.79M | Hold |
194,900
| – | – | 0.03% | 124 |
|
2017
Q2 | $3.37M | Hold |
194,900
| – | – | 0.04% | 120 |
|
2017
Q1 | $2.15M | Hold |
194,900
| – | – | 0.02% | 121 |
|
2016
Q4 | $2.83M | Hold |
194,900
| – | – | 0.04% | 114 |
|
2016
Q3 | $4.79M | Hold |
194,900
| – | – | 0.05% | 114 |
|
2016
Q2 | $3.93M | Hold |
194,900
| – | – | 0.04% | 110 |
|
2016
Q1 | $5.13M | Sell |
194,900
-195,100
| -50% | -$5.13M | 0.05% | 115 |
|
2015
Q4 | $39.6M | Buy |
390,000
+225,000
| +136% | +$22.9M | 0.36% | 58 |
|
2015
Q3 | $29.4M | Hold |
165,000
| – | – | 0.3% | 61 |
|
2015
Q2 | $36.7M | Buy |
165,000
+3,000
| +2% | +$666K | 0.31% | 62 |
|
2015
Q1 | $32.2M | Hold |
162,000
| – | – | 0.27% | 63 |
|
2014
Q4 | $23.2M | Buy |
162,000
+24,000
| +17% | +$3.43M | 0.22% | 67 |
|
2014
Q3 | $18.1M | Hold |
138,000
| – | – | 0.19% | 73 |
|
2014
Q2 | $17.4M | Buy |
138,000
+5,000
| +4% | +$631K | 0.2% | 64 |
|
2014
Q1 | $17.5M | Sell |
133,000
-24,000
| -15% | -$3.16M | 0.22% | 65 |
|
2013
Q4 | $18.4M | Buy |
157,000
+19,000
| +14% | +$2.23M | 0.27% | 65 |
|
2013
Q3 | $14.4M | Hold |
138,000
| – | – | 0.26% | 61 |
|
2013
Q2 | $11.9M | Buy |
+138,000
| New | +$11.9M | 0.25% | 62 |
|